NW Biotherapeutics 17WTS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NW Biotherapeutics 17WTS Derivative, CUSIP 66737P113.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for NW Biotherapeutics 17WTS Derivative, CUSIP 66737P113.